Humana (HUM) Financials

$398.98

$-2.57 (-0.64%)

As on 08-Sep-2026 10:43EDT

Market cap

$48,217 Mln

Revenue (TTM)

$145,679 Mln

P/E Ratio

38.5

P/B Ratio

2.5

Div. Yield

0.9 %

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Operating Revenue	145,679.00	129,664.00	117,811.00	106,440.00	92,922.00	83,648.00
Cost of Revenue	125,789.00	110,812.00	100,664.00	88,394.00	75,690.00	69,199.00
Gross Profit	19,890.00	18,852.00	17,147.00	18,046.00	17,232.00	14,449.00
Operating Expenses	17,868.00	17,399.00	15,520.00	14,726.00	13,668.00	11,030.00
Operating Profit (EBIT)	2,022.00	1,453.00	1,627.00	3,320.00	3,564.00	3,419.00
Other Income	--	--	--	--	165.00	597.00
Profit before Tax	1,614.00	1,453.00	1,627.00	3,320.00	3,564.00	3,419.00
Provision for Tax	298.00	250.00	413.00	836.00	762.00	485.00
Profit after Tax (Net Income)	1,278.00	1,188.00	1,207.00	2,489.00	2,806.00	2,933.00
Minority Interest	-16.00	-15.00	-7.00	5.00	4.00	-1.00
Consolidated Profit	-601.00	1,188.00	1,207.00	2,489.00	2,806.00	2,933.00

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Shareholder's Funds	19,213.00	17,657.00	16,375.00	16,262.00	15,311.00	16,080.00
Minority Interest	-16.00	--	--	--	59.00	23.00
Non-Current Liabilities	14,912.00	20,699.00	18,610.00	18,628.00	16,723.00	18,152.00
Current Liabilities	23,007.00	10,314.00	11,257.00	11,946.00	11,632.00	10,493.00
Total Liabilities	80,203.00	48,750.00	46,312.00	46,892.00	43,725.00	44,748.00

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Non-Current Assets	17,110.00	41,280.00	41,387.00	40,163.00	36,990.00	39,540.00
Current Assets	40,086.00	7,470.00	4,925.00	6,729.00	6,735.00	5,208.00
Total Assets	97,282.00	48,750.00	46,312.00	46,892.00	43,725.00	44,748.00
Total Debt*	14,247.00	12,937.00	12,260.00	12,269.00	11,753.00	13,225.00
Net Current Assets	--	--	--	--	--	--

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Cash From Operating Activities	--	921.00	2,966.00	3,981.00	4,587.00	2,262.00
Cash Flow from Investing Activities	--	2,273.00	-2,952.00	-3,492.00	-1,006.00	-6,556.00
Cash from Financing Activities	--	-1,215.00	-2,487.00	-856.00	-1,914.00	3,015.00
Net Cash Inflow / Outflow	--	--	--	--	1,667.00	-1,279.00

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Adjusted EPS ($)	10.56	9.87	9.99	20.32	22.33	22.81
Cash EPS ($)	--	16.72	18.01	27.81	29.06	28.35
Adjusted Book Value ($)	--	146.73	135.60	132.79	121.86	125.03
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	7.65	24.56	32.51	36.51	17.59
Free Cash Flow per Share ($)	--	3.12	19.80	24.31	27.59	7.36

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
ROCE (%)	--	4.01	4.22	8.95	9.96	11.69
ROE (%)	6.85	6.98	7.40	15.77	17.88	19.68
ROA (%)	1.64	2.50	2.59	5.49	6.34	7.35
EBIT Margin (%)	1.59	1.61	1.94	3.58	4.27	4.48
Net Margin (%)	0.88	0.92	1.02	2.34	3.01	3.48
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Revenue Growth (%)	18.33	0.10	0.11	0.15	0.11	0.08
EBIT Growth (%)	-15.89	-8.88	-40.02	-3.83	5.87	-24.45
Net Profit Growth (%)	-19.62	-1.57	-51.51	-11.30	-4.33	-12.89
EPS Growth (%)	-19.07	-0.01	-0.51	-0.09	-0.02	-0.11
Book Value Growth (%)	5.24	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Price / Earnings	38.46	25.94	25.38	22.52	22.93	20.34
Price / Book Value	2.47	1.75	1.87	3.45	4.20	3.71
Dividend Yield (%)	0.87	--	--	--	--	--
EV/EBITDA	--	8.20	6.90	9.94	11.88	12.63
Close Price ($)	397.22	256.13	253.71	457.81	512.19	463.86
High Price ($)	398.80	315.35	474.92	541.21	571.30	475.44
Low Price ($)	163.11	206.87	213.31	423.29	351.20	370.22
Market Cap ($ Cr)	48,217.05	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debt to Equity	0.62	0.73	0.75	0.75	0.77	0.82
Short term debt to equity ratio	0.12	0.01	0.04	0.10	0.15	0.13
Current Ratio	1.74	0.72	0.44	0.56	0.58	0.50
Quick Ratio	1.74	--	--	3.24	2.97	3.04
Interest Coverage	3.29	3.30	3.47	7.73	9.89	11.49

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debtors to sales (%)	3.91	2.52	2.30	1.91	1.80	2.17
Asset Turnover	1.87	2.73	2.53	2.35	2.10	2.10
Receivable days	--	8.41	7.35	6.36	6.86	6.44
Inventory Days	--	--	-116.19	-123.71	-131.65	-135.88
Payable days	--	33.09	36.90	39.57	41.46	42.36
Cash Conversion Cycle	--	--	-145.74	-156.91	-166.26	-171.79

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement ($ Mln)